The answer is <span>A. Dermal tissue, ground tissue, and vascular tissue respectively.
<em>
</em>1. <em>Epidermis is dermal tissue. </em>Dermal tissue covers the plant from the outside. It consists of epidermis and periderm. Epidermis is a single layer that covers young plants.
2. <em>Sclerenchyma is ground tissue.</em> Ground tissue has a variety of functions. It consists of sclerenchyma and parenchyma. The function of sclerenchima is support and strength of roots, stems, and leaves.
3. <em>Phloem is vascular tissue.</em> Vascular tissue has a role in transport of minerals, water, and organic compounds. It consists of phloem and xylem. Phloem transport organic compounds, such as carbohydrates, hormones, etc.
</span>
Answer:
Glycogen synthase is phosphorylated at only one site.
Explanation:
Glycogen synthase has multiple sites where phosphorylation can occur. Glycogen synthase may have 9 or more sites where it can be phosphorylated as a result of which it's activity is down regulated. It simply means that the regulation of this enzyme does not occur through binary on/off switching, in fact it's activity is modulated over a wide range in response to various signals.
In contrast to glycogen phosphorylase which gets activated when it is phosphorylated at it's serine residues, glycogen synthase gets inactivated by phosphorylation.
As soon as another enzyme GSK3β phosphorylates glycogen synthase, it gets inactivated as a result of which glycogen synthesis halts in the liver.
Answer:
Explanation:
Synovial joints, often referred to as joints, are composed of two or more bones with a gap between the opposite bone surfaces, connected only by the fibrous connective tissue membrane around them. The synovial joint is the main form of bone joint and has great mobility.
<em>The preclinical trial of therapy against Alzheimer’s disease (AD) is an essential and complex step. It functions as a bridge between candidate discovery and clinical development since it constantly provides us with new information on pieces of the complex AD puzzle. Analysis of this information is likely to reveal patterns of pharmacological interactions instead of the single potential drug target. A group of well-trained, knowledgeable medicinal biochemists in Alzheimacy with decades of experience in preclinical research are willing to work with leaders and scientists from academia, pharmaceutical and biotechnology companies around the world to further develop more promising and stringent therapeutics for AD.</em>
<em>https://www.creativebiomart.net/alzheimacy/solutions/preclinical-development/</em>
That would be biochemistry.
Oxygen is what plants release into the atmosphere
